Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
Keyword(s):
2020 ◽
2013 ◽
Vol 19
(4)
◽
pp. 809-820
◽
Keyword(s):
2021 ◽
2013 ◽
Keyword(s):
2017 ◽
Vol 146
(2)
◽
pp. 319-326
◽